Literature DB >> 10874055

The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury.

M H Griffiths1, L Papadaki, G H Neild.   

Abstract

Some features of the vascular and glomerular pathology of primary antiphospholipid syndrome (APS) are well recognized, but we describe novel glomerular ultrastructural changes that we consider to be pathognomonic of APS. Renal biopsies from eight patients with APS were examined by light and electron microscopy. All had anti-cardiolipin antibodies, and the clinical presentation ranged from fulminant multi-system disease to isolated proteinuria. By light microscopy, the hexamine silver stain showed a combination of glomerular basement membrane wrinkling and reduplication. By electron microscopy, redundant, wrinkled segments of basement membrane were accompanied by a 'new' straighter thin basement membrane adjacent to the endothelium. In two cases the presence of these antibodies was not suspected clinically, and there was no clinical history or evidence of a thrombotic microangiopathy. We describe a distinctive glomerular lesion that represents an unexplained form of endothelial injury in this syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 10874055     DOI: 10.1093/qjmed/93.7.457

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  12 in total

Review 1.  Renal involvement in antiphospholipid syndrome.

Authors:  Francisco Vileimar Andrade de Azevedo; Diego Germano Maia; Jozelio Freire de Carvalho; Carlos Ewerton Maia Rodrigues
Journal:  Rheumatol Int       Date:  2018-05-05       Impact factor: 2.631

Review 2.  Renal manifestations of the antiphospholipid syndrome.

Authors:  David D'Cruz
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

3.  Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.

Authors:  Gian Luca Erre; Luisanna Bosincu; Rossana Faedda; Patrizia Fenu; Antonio Masala; Marcella Sanna; Loredana Taras; Maria Giovanna Longu; Marco Piras; Giovanni Soro; Andrea Ercole Satta; Giuseppe Passiu
Journal:  Rheumatol Int       Date:  2014-04       Impact factor: 2.631

Review 4.  Antiphospholipid syndrome presenting as unilateral renal artery occlusion: case report and literature review.

Authors:  Doron Boltin; Victoria Boguslavski; Lior Sagi; Yoav Goor; Ori Elkayam
Journal:  Rheumatol Int       Date:  2008-11-27       Impact factor: 2.631

Review 5.  Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Authors:  Sonja Praprotnik; Dusan Ferluga; Alenka Vizjak; Anastazija Hvala; Tadej Avcin; Blaz Rozman
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 6.  What nephrolopathologists need to know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions?

Authors:  Muhammed Mubarak; Hamid Nasri
Journal:  J Nephropathol       Date:  2014-01-01

Review 7.  Renal involvement in antiphospholipid syndrome.

Authors:  Savino Sciascia; Maria José Cuadrado; Munther Khamashta; Dario Roccatello
Journal:  Nat Rev Nephrol       Date:  2014-03-18       Impact factor: 28.314

8.  Catastrophic antiphospholipid syndrome in a 14-year-old child.

Authors:  George Tsirpanlis; George Moustakas; Eleni Sakka; George Triantafyllis; Flora Sotsiou; Helen Liapis; Panos Ziroyannis
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.651

9.  Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.

Authors:  Jakob Gerhardsson; Birgitta Sundelin; Agneta Zickert; Leonid Padyukov; Elisabet Svenungsson; Iva Gunnarsson
Journal:  Arthritis Res Ther       Date:  2015-04-27       Impact factor: 5.156

10.  Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases.

Authors:  Hui Zheng; Yi Chen; Wen Ao; Yan Shen; Xiao-wei Chen; Min Dai; Xiao-dong Wang; Yu-cheng Yan; Cheng-de Yang
Journal:  Arthritis Res Ther       Date:  2009-06-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.